That's the challenge Baker Institute for Animal Health researchers Dr.
Photo: Allison Usavage/Cornell University When someone experiences a stroke, every minute counts.
The sooner doctors can determine what kind of stroke a patient is having, the sooner they can begin treatment that may save brain function and improve recovery.
Yet diagnosing the most common type of stroke, acute ischemic stroke, isn't always straightforward.
In fact, studies have shown that nearly one in six strokes is initially missed, which significantly increases the risk of cognitive impairment, disability and death.
Alexander Travis, professor of reproductive biology, and Dr.
Roy Cohen, research assistant professor, set out to help solve.
While conducting research at the Baker Institute, Travis and Cohen developed an innovative technology that could rapidly detect a biomarker associated with acute ischemic stroke using a simple blood test.
Recognizing its potential to improve patient care, together with David Fischell ’75, M.S.E.
’80, a Cornell Trustee Emeritus, they co-founded TETmedical to advance the discovery beyond the research laboratory and into clinical development.
That journey recently reached an important milestone.
The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.
Source university website: Cornell University College of Veterinary Medicine
https://www.vet.cornell.edu/about-us/news/20260710/stroke-test-tech-receives-breakthrough-status-fda
Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.